| 肺癌融合分布 | |||
| 融合partner | 检测阳性例数/总检测例数 | 百分比 | |
| NSCLC | 1281 | ||
| ALK | EML4 | 62 | 4.84% |
| KIF5B | 3 | 0.23% | |
| ROS1 | CD74 | 14 | 1.09% |
| EZR | 4 | 0.31% | |
| GOPC | 4 | 0.31% | |
| SLC34A2 | 1 | 0.08% | |
| TPM3 | 2 | 0.16% | |
| RET | KIF5B | 8 | 0.62% |
| CCDC6 | 1 | 0.08% | |
| NTRK1 | 0 | 0.00% |
肺癌融合分布
相关推荐
暂无相关推荐
评论 (0)
